Single Anastomosis Sleeve Jejunal (SAS-J) Bypass

NCT02870530 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2022-03-11

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy of single anastomoses sleeve jejunal bypass as a treatment for morbid obesity

Conditions

  • Morbid Obesity

Interventions

PROCEDURE

Single Anastomosis Sleeve Jejunal (SAS-J) Bypass

Single Anastomosis Sleeve Jejunal (SAS-J) Bypass as A treatment for Morbid

Sponsors & Collaborators

  • Minia University

    lead OTHER

Principal Investigators

  • Alaa M Sewefy, MD · Lecturer & consultant of general surgery, Department of surgery, Minia university hospital, Egypt.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-04-30
Completion
2017-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02870530 on ClinicalTrials.gov